Navigating Cannabis Use in Psychiatric Populations: Drug–Drug Interactions and Other Pharmacologic Considerations

Increasing use of medical and recreational cannabis can lead to safety concerns if healthcare professionals and patients are not aware of potential interactions with other medications. This downloadable slideset presented at CCO’s 2024 Psychopharmacology Update covers potential cannabis-related drug–drug interaction concerns that may arise in psychiatric populations and presents strategies for patient communication and education.

Share

Program Content

Events

Activities

Cannabis DDI slideset
Navigating Cannabis Use in Psychiatric Populations: Drug–Drug Interactions and Other Pharmacologic Considerations
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 27, 2024

Expires: November 26, 2025

Faculty

cover img faculity

John S. Markowitz, PharmD, BCPP

Professor
University of Florida College of Pharmacy
Department of Pharmacotherapy and Translational Research
Gainesville, Florida

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

This activity is not commercially supported.

Independent Educational Activity